Cancer-Killing virus trial for breast cancer pulled before it started
NCT ID NCT07150767
First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 30 times
Summary
This study planned to test a new treatment that uses a modified virus to attack cancer cells, combined with standard pre-surgery therapy, in people with locally advanced breast cancer. The goal was to check safety and find the best dose. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED BREAST CANCER (LABC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second People's Hospital of Shandong Province
Jinan, Shandong, 250022, China
Conditions
Explore the condition pages connected to this study.